Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: Roles in specific gene regulation and cellular transformation

Molecular Endocrinology

Volumn 17, Issue 6, 2003, Pages 1155-1166

  Hwang, Jung Hwan ^a   Kim, Dong Wook ^a   Suh, Jae Mi ^a   Kim, Ho ^a   Song, Jung Hun ^a   Hwang, Eun Suk ^a   Park, Ki Cheol ^a   Chung, Hyo Kyun ^a   Kim, Jin Man ^a   Lee, Tae Hoon ^b   Yu, Dae Yeul ^b   Shong, Minho ^a,c  

^a Chungnam National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Chungnam National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; INTERCELLULAR ADHESION MOLECULE 1; JANUS KINASE; PROTEIN RET; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; TYROSINE; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE CONTROL; GENE INDUCTION; MOUSE; NONHUMAN; ONCOGENE RET; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THYROID CARCINOMA;

CARCINOMA, PAPILLARY; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ONCOGENE PROTEINS, FUSION; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; THYROID NEOPLASMS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

ANIMALIA; JANUS;

EID: 0038178993     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2002-0401     Document Type: Article

References (52)

1. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA 2000 PAX8-PPAR-γ1 fusion oncogene in human thyroid carcinoma. Science 289: 1357-1360
2. Santoro M, Melillo RM, Carlomagno F, Fusco A, Vecchio G 2002 Molecular mechanisms of RET activation in human cancer. Ann NY Acad Sci 963:116-121
3. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A, Vecchio G 1990 PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557-563
4. Pierotti MA, Bongarzone I, Grazia Borrello M 1996 Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells. Genes Chromosomes Cancer 16:1-14
5. Tallini G, Asa SL 2001 RET oncogene activation in papillary thyroid carcinoma. Adv Anat Pathol 8:345-354
6. Tong Q, Li Y, Smanik PA, Fithian LJ, Xing S, Mazzaferri EL, Jhiang SM 1995 Characterization of the promoter region and oligomerization domain of H4 (D10S170), a gene frequently rearranged with the ret proto-oncogene. Oncogene 10:1781-1787
7. Salvatore D, Barone MV, Salvatore G, Melillo RM, Chiappetta G, Mineo A, Fenzi G, Vecchio G, Fusco A, Santoro M 2000 Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins. J Clin Endocrinol Metab 85:3898-3907
8. Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G, Fusco A 1996 Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene 12: 1821-1826
9. Jhiang SM, Cho JY, Ryu KY, DeYoung BR, Smanik PA, McGaughy VR, Fischer AH, Mazzaferri EL 1996 Targeted expression of the RET/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137:375-378
10. Buckwalter TL, Venkateswaran A, Lavender M, La Perle KM, Cho JY, Robinson ML, Jhiang SM 2002 The roles of phosphotyrosines-294, -404, and -451 in RET/PTCI-induced thyroid tumor formation. Oncogene 21:8166-8172
11. Alberti L, Borrello MG, Ghizzoni S, Torriti F, Rizzetti MG, Pierotti MA 1998 Grb2 binding to the different isoforms of Ret tyrosine kinase. Oncogene 17:1079-1087
12. Kasus-Jacobi A, Bereziat V, Perdereau D, Girard J, Burnol AF 2000 Evidence for an interaction between the insulin receptor and Grb7. A role for two of its binding domains, PIR and SH2. Oncogene 19:2052-2059
13. Pandey A, Duan H, Di Fiore PP, Dixit VM 1995 The Ret receptor protein tyrosine kinase associates with the SH2-containing adapter protein Grb10. J Biol Chem 270: 21461-21463
14. Borrello MG, Alberti L, Arighi E, Bongarzone I, Battistini C, Bardelli A, Pasini B, Piutti C, Rizzetti MG, Mondellini P, Radice MT, Pierotti MA 1996 The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cγ. Mol Cell Biol 16:2151-2163
15. Melillo RM, Santoro M, Ong SH, Billaud M, Fusco A, Hadari YR, Schlessinger J, Lax I 2001 Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol Cell Biol 21:4177-4187
16. Besset V, Scott RP, Ibanez CF 2000 Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. J Biol Chem 275: 39159-39166
17. Chiariello M, Visconti R, Carlomagno F, Melillo RM, Bucci C, de Franciscis V, Fox GM, Jing S, Coso CA, Gutkind JS, Fusco A, Santoro M 1998 Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret. Oncogene 16:2435-2445
18. Segouffin-Cariou C, Billaud M 2000 Transforming ability of MEN2A-RET requires activation of the phosphatidyl-inositol 3-kinase/AKT signaling pathway. J Biol Chem 275:3568-3576
19. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L 1993 Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460
20. Barone MV, Sepe L, Melillo RM, Mineo A, Santelli G, Monaco C, Castellone MD, Tramontano D, Fusco A, Santoro M 2001 RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho. Oncogene 20:6973-6982
21. Zhong Z, Wen Z, Darnell Jr JE 1994 Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95-98
22. Bromberg JF 2001 Activation of STAT proteins and growth control. Bioessays 23:161-169
23. Bromberg J, Darnell Jr JE 2000 The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19:2468-2473
24. Wen Z, Zhong Z, Darnell Jr J E 1995 Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-250
25. Bromberg JF, Wr-zeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell Jr JE 1999 Stat3 as an oncogene. Cell 98:295-303
26. Cao X, Tay A, Guy G, and Tan YH 1996 Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol Cell Biol 16:1595-1603
27. Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell Jr JE 1998 Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol 18:2553-2558
28. Coffer PJ, Koenderman L, de Groot RP 2000 The role of STATs in myeloid differentiation and leukemia. Oncogene 19:2511-2522
29. Takemoto S, Mulloy JC, Cereseto A, Migone TS, Patel BK, Matsuoka M, Yamaguchi K, Takatsuki K, Kamihira S, White JD, Leonard WJ, Waldmann T, Franchini G 1997 Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci USA 94:13897-13902
30. Li L, Shaw PE 2002 Autocrine-mediated activation of STAT3 correlates with cell proliferation in breast carcinoma lines. J Biol Chem 277:17397-17405
31. Song JI, Grandis JR 2000 STAT signaling in head and neck cancer. Oncogene 19:2489-2495
32. Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S, Weinstein IB 2002 Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res 62:3351-3355
33. Fukada T, Ohtani T, Yoshida Y, Shirogane T, Nishida K, Nakajima K, Hibi M, Hirano T 1998 STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J 17:6670-6677
34. Karni R, Jove R, Levitzki A 1999 Inhibition of pp60c-Src reduces BcI-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Oncogene 18:4654-4662
35. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS, Jove R 1999 Constitutive activation of Star3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10:105-115
36. Schuringa JJ, Wojtachnio K, Hagens W, Vellenga E, Buys CH, Hofstra R, Kruijer W 2001 MEN2A-RET-induced cellular transformation by activation of STAT3. Oncogene 20:5350-5358
37. Yamanaka Y, Nakajima K, Fukada T, Hibi M, Hirano T 1996 Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J 15:1557-1565
38. Sinibaldi D, Wharton W, Turkson J, Bowman T, Pledger W J, Jove R 2000 Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19:5419-5427
39. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H 2002 Constitutive Stat3 activity up-regurates VEGF expression and tumor angiogenesis. Oncogene 21:2000-2008
40. Cantwell CA, Sterneck E, Johnson PF 1998 Interleukin-6-specific activation of the C/EBPδ gene in hepatocytes is mediated by Stat3 and Sp1. Mol Cell Biol 18: 2108-2117
41. Santoro M, Carlomagno F, Hay ID, Herrmann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, Della Porta G, Berger N 1992 Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 89:1517-1522
42. Santoro M, Sabino N, Ishizaka Y 1993 Involvement of RET oncogene in human tumors: specificity of RET activation to thyroid tumors. Br J Cancer 68:460-464
43. Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, Jove R 1995 Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269:81-83
44. Besser D, Bromberg JF, Darnell Jr JE, Hanafusa H 1999 A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. Mol Cell Biol 19:1401-1409
45. Nguyen KT, Zong CS, Uttamsingh S, Sachdev P, Bhanot M, Le MT, Chan JL, Wang LH 2002 The role of phosphatidylinositol 3-kinase, rho family GTPases, and STAT3 in Ros-induced cell transformation. J Biol Chem 277:11107-11115
46. Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y, Kim JD 2000 Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci USA 97:4227-4232
47. Kim DW, Hwang JH, Suh JM, Kim H, Song JH, Hwang ES, Hwang IY, Park KC, Chung HK, Kim JM, Park J, Hemmings BA, Shong M, RET/PTC tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative P13K-independent pathway to activate PDK1. Mol Endocrinol, in press
48. Aaronson DS, Horvath CM 2002 A road map for those who know JAK-STAT. Science 296:1653-1655
49. Chung J, Park ES, Kim D, Suh JM, Chung HK, Kim J, Kim H, Park SJ, Kwon OY, Ro HK, Shong M 2000 Thyrotropin modulates interferon-γ-mediated intercellular adhesion molecule-1 gene expression by inhibiting Janus kinase-1 and signal transducer and activator of transcription-1 activation in thyroid cells. Endocrinology 141:2090-2097
50. Park ES, Kim H, Suh JM, Park SJ, Kwon OY, Kim YK, Ro HK, Cho BY, Chung J, Shong M 2000 Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells. Mol Endocrinol 14: 440-448
51. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH, Koeffler HP 1993 High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 91:179-184
52. Park ES, You SH, Kim H, Kwon OY, Ro HK, Cho BY, Taniguchi SI, Kohn LD, Shong M 1999 Hormone-dependent regulation of intercellular adhesion molecule-1 gene expression: cloning and analysis of 5′-regulatory region of rat intercellular adhesion molecule-1 gene in FRTL-5 rat thyroid cells. Thyroid 9:601-612